GemVax & KAEL said Friday that GV1001, its treatment for progressive supranuclear palsy (PSP), has received orphan drug ...

Korean researchers have found no direct link between Covid-19 vaccination and menstrual changes such as abnormal uterine ...

LG H&H’s luxury skincare brand THE WHOO has surpassed 20 trillion won ($13.9 billion) in cumulative net sales, cementing its ...

The Korean Diabetes Association (KDA) has removed metformin as the preferred first-line treatment for type 2 diabetes in its newly revised 2025 Clinical Practice Guidelines for Diabetes, citing a lack ...

In Korea, Eli Lilly and Novo Nordisk are pushing for national health insurance coverage for their diabetes drugs Mounjaro and ...

GC Biopharma reported a return to profitability in the first quarter of 2025, driven by improved blood product margins in ...

Korean biotech OliX Pharmaceuticals has locked in a $3 million milestone payment from China’s Jiangsu Hansoh Pharmaceutical ...

Pfizer Korea has secured reimbursement for Lorviqua (lorlatinib) as a first-line treatment for ALK-positive metastatic ...

Dong-A Socio Holdings posted a 31 percent jump in first-quarter operating profit, powered by an 854 percent surge at ...

Korean patients with atopic dermatitis (AD) -- the most common form of eczema -- aren’t short on complaints, but for many, it ...

Korea’s ambitious plan to raise a K-Bio Vaccine Fund worth 1 trillion won ($703 million) for biotech innovation by 2025 is ...

The Korean government is taking action to address regulatory bottlenecks that have made it difficult for rapidly evolving ...